Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium

Journal of Rheumatology

Volumn 29, Issue 1, 2002, Pages 39-45

  Paavonen, K ^a   Mandelin, J ^a   Partanen, T ^a   Jussila, L ^a   Li, T F ^a   Ristimaki A ^a   Alitalo, K ^a   Konttinen, Y T ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Endothelial growth factors; Inflammation; Lymphatic endothelium; Pathologic angiogenesis; Rheumatoid arthritis

Indexed keywords

AUROTHIOMALATE; BIOCHEMICAL MARKER; CYCLOSPORIN; HYDROXYCHLOROQUINE; LAMININ; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; SALAZOSULFAPYRIDINE; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ANGIOGENESIS; ARTHRITIS; ARTICLE; BLOOD VESSEL; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL; LYMPH VESSEL ENDOTHELIUM; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SYNOVIOCYTE; SYNOVIUM; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ARTHRITIS; BLOOD VESSELS; CYTOKINES; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC SYSTEM; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RNA, MESSENGER; STROMAL CELLS; SYNOVIAL MEMBRANE; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR D; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 0036137724     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Angiogenesis in cancer, vascular, rheumatoid and other disease
2. Blood vessel formation: What is its molecular basis?
3. DNA synthesis in prolyl 4-hydroxylase positive fibroblasts in situ in synovial tissue. An autoradiography-immunoperoxidase double labeling study
4. Aberrant vascularity and von Willebrand factor distribution in inflamed synovial membrane
5. Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?
6. Suppression of arthritis and protection from bone destruction by treatment with TNP-470/AGM-1470 in a transgenic mouse model of rheumatoid arthritis
7. Neutralization of vascular endothelial growth factor prevents collagen-induced arthritis and ameliorates established disease in mice
8. Angiogenesis in arthritis: Role in disease pathogenesis and as a potential therapeutic target
9. Vascular permeability factor/endothelial growth factor (VPFNEGF): Accumulation and expression in human synovial fluids and rheumatoid synovial tissue
10. Expression of vascular endothelial growth factor isoforms and their receptors Flt-1, KDR, and neuropilin-1 in synovial tissues of rheumatoid arthritis
11. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis
12. Increased circulating vascular endothelial growth factor is correlated with disease activity in polyarticular juvenile rheumatoid arthritis
13. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and Kdr (VEGFR-2) receptor tyrosine kinases
14. Molecular cloning of murine FLT and FLT4
15. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C
16. Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia
17. Concurrent induction of lymphangiogenesis, angiogenesis and macrophage recruitment by VEGF-C in melanoma
18. Vascular endothelial growth factor C induces angiogenesis in vivo
19. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia
20. Adenoviral expression of VEGF-C induces lymphangiogenesis in the skin
21. VEGF and VEGF-C: Specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane
22. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice
23. Molecular cloning of a novel vascular endothelial growth factor, VEGF-D
24. Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family
25. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
26. C-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro
27. Signaling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice
28. Expression of the fms-like tyrosine kinase FLT4 gene becomes restricted to endothelium of lymphatic vessels during development
29. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3
30. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer
31. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors
32. Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing
33. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth
34. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
35. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy
36. Monoclonal antibody PAL-E specific for endothelium
37. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma
38. Angiogenesis and arthritis
39. Demonstration of lymphatics in human synovial tissue